Hier berichtet das Leibniz-Institut für Virologie (LIV). #LeibnizWGL Webseite: https://www.leibniz-liv.de/ Impressum: https://www.leibniz-liv.de/impressumhttps://bsky.app/profile/leibnizliv.bsky.socialhttps://bsky.app/profile/leibnizliv.bsky.social/post/3mkia5rz5lb2w28th International Workshop from @ksvirus.org is coming to Hamburg. Can't wait to welcome you to our harbour city. We are very excited for the scientific discussion and exchange at @cssbhamburg.bsky.social. Register here: https://ksvirus.pulse.ly/ioh7jdxmmg27 Apr 2026 13:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mkia5rz5lb2whttps://bsky.app/profile/leibnizliv.bsky.social/post/3mjkn45lgcs26Biological sex is a key determinant of immune responses, shaping susceptibility to infection and responses to therapy. The EFIS Congress Sex Differences in Immunity provides a platform for exploring kex questions in this field. Registration is now open. #Immunology #SexDifferences #EFIS [contains quote post or other embedded content]15 Apr 2026 19:31 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mjkn45lgcs26https://bsky.app/profile/leibnizliv.bsky.social/post/3mjf4vaje7s2qDFG funds nationwide adenovirus Research Group FOR 5898 “AdBHealth” with €5.7 million. LIV contributes two projects on viral DNA persistence and capsid sorting. Aim: better understand infections & develop safer vaccines, gene therapies & cancer treatments. More👉 https://www.leibniz-liv.de/en/news/news-and-press/adenovirus-research-group-funded-by-the-dfg13 Apr 2026 14:58 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mjf4vaje7s2qhttps://bsky.app/profile/leibnizliv.bsky.social/post/3migqogb63q2a✨ The moment has arrived! ✨ Prof. Dr. Stephanie Pfänder officially starts her W3 Professorship at @uni-hamburg.de today – supported by the Leibniz Professorship Program of @leibniz-gemeinschaft.de. 🔗https://leibniz-liv.pulse.ly/3hj5ndxht0 #UniverstätHamburg #LeibnizProfessorinnenprogramm01 Apr 2026 12:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3migqogb63q2ahttps://bsky.app/profile/leibnizliv.bsky.social/post/3mibz4fx6uk2j🚨Thrilled about this new paper from our collaborators at the Ott Lab & Roan Lab (@gladstoneinst.bsky.social)! As part of the HOPE Martin Delaney Collaboratory, Ulrike Lange & team (LIV) contributed to characterizing ZNF254 as a novel HIV-1 transcriptional repressor🎉🔗doi:10.1016/j.immuni.2026.01.029 [contains quote post or other embedded content]30 Mar 2026 15:47 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mibz4fx6uk2jhttps://bsky.app/profile/leibnizliv.bsky.social/post/3mhzubwqqhr2dCongratulations to Dr. Shirin Geravandi on receiving the Poster Award, sponsored by the Journal of Virology for her work on immune reponses of HIV-1-exposed uninfected children at last week’s 2026 Annual Meeting. #GfV2026 #Virology #GlobalHealth #Immunology #HIVResearch27 Mar 2026 09:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhzubwqqhr2dhttps://bsky.app/profile/leibnizliv.bsky.social/post/3mhxult35df23Pünktlich zum Frühlingsanfang legen wir am LIV eine neue Wildblumenwiese an! In den kommenden Monaten soll eine brachliegende Grünfläche in eine artenreiche Oase für Insekten umgewandelt werden. #LIV #GreenInitiative26 Mar 2026 15:00 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhxult35df23https://bsky.app/profile/leibnizliv.bsky.social/post/3mhfn7abhh42kDay 3 at #GfV2026! Our researchers are presenting at the final poser session today. Stop by to discuss the science, share ideas, and connect with us! 🧠 👉P394, P400, P407, P449, P451, P531, P537 📍 Check the conference program for poster locations. #GfV #PosterSession #Virology #Research19 Mar 2026 08:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhfn7abhh42khttps://bsky.app/profile/leibnizliv.bsky.social/post/3mhda3m3nq72nDay 2 at #GfV2026! Our researchers love to discuss their findings with you at the poster session today. Stop by to discuss the science and share ideas. 🧠 👉P175, P204, P294, P237, P264, P295, P339 #GfV #Conference #Virology18 Mar 2026 09:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhda3m3nq72nhttps://bsky.app/profile/leibnizliv.bsky.social/post/3mhbh3ptzpg26🆕New study maps the NS4B interactome across 8 orthoflaviviruses, uncovering conserved host dependencies. Group of Dr. Pietro Scaturro and collaborators found UBA5/UFMylation emerges as key for viral replication & inhibition reduces infection in vitro & in vivo → https://rdcu.pulse.ly/lielhqvqwu https://Dr.pulse.ly/28rpkkue8m17 Mar 2026 16:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhbh3ptzpg26https://bsky.app/profile/leibnizliv.bsky.social/post/3mhambhasjo2jDay 1 at #GfV2026 is here! Some of our researchers will be presenting their work at the poster session later today. Stop by to discuss the science and share ideas. 🧠 👉P066,P091,P095,P138, 📍 See the conference program for more information and locations. #GfV #PosterSession #Virology #Research17 Mar 2026 08:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhambhasjo2jhttps://bsky.app/profile/leibnizliv.bsky.social/post/3mhaiw3r77j2kTwo of our researchers, Isabel Korth & Lisa Brauckmann, are presenting today in the Pathogenesis & Persistence session at #GfV2026. If you're at the meeting, we look forward to the discussions and scientific exchange. #GfV2026 #Virology17 Mar 2026 07:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mhaiw3r77j2khttps://bsky.app/profile/leibnizliv.bsky.social/post/3mh5yhibp2f2yWe’ll be at #GfV2026 (Mar 17–19), presenting posters and oral presentations on our latest virology research. Each morning we’ll share a short preview of the work being presented. If you’re attending, we’d be happy to connect and discuss our research. #Virology #Research16 Mar 2026 07:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mh5yhibp2f2yhttps://bsky.app/profile/leibnizliv.bsky.social/post/3mgxfaeqbom2gWe’ll be at #GfV2026 next week (March 17–19), where researchers from our institute will present posters and oral presentations. Looking forward to exchanging ideas with colleagues and discussing current work in virology. Starting Tuesday, we’ll share short poster previews here.13 Mar 2026 16:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mgxfaeqbom2ghttps://bsky.app/profile/leibnizliv.bsky.social/post/3mgulamnrtx2oWe're delighted that Prof. Maya Topf (LIV) is joining as fellow of the new #MaxPlanckSchool of Biomedical Artificial Intelligence. The school will connect biomedicine and AI & bring together expertise from 32 fellows across 24 institutions. 👉 https://maxplanckschools.pulse.ly/vdicv8igar12 Mar 2026 14:09 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mgulamnrtx2ohttps://bsky.app/profile/leibnizliv.bsky.social/post/3mgtpuwfbcc2k💡Das BK-Polyomavirus tragen (BKPyV) ~90 % der Erwachsenen – für immungeschwächte und Transplantationspatient*innen kann es Nierenschäden und Transplantatabstoßung verursachen, Therapien fehlen bisher. Als Teil des DZIF suchen wir neue antivirale Wirkstoffe gegen BKPyV. #WorldKidneyDay12 Mar 2026 05:59 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mgtpuwfbcc2khttps://bsky.app/profile/leibnizliv.bsky.social/post/3mg7wbf3jpk2eAn important question ahead of International Women’s Day: Why do women and men respond differently to infections? 🧔👩‍🦰 Our Scientific Director explored this in his talk on sex-specific antiviral immunity at the “Sex Differences in Immunity & Disease” symposium at Gladstone Institutes. #PrecisionMed04 Mar 2026 09:00 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mg7wbf3jpk2ehttps://bsky.app/profile/leibnizliv.bsky.social/post/3mg3n2umuo223TLR8 helps the body detect viral genetic material — but what happens when it’s mutated? A new study in @insight.jci.org from scientists from @leibnizliv.bsky.social, DZKJ and collaborators combines computational modeling and functional experiments to find out: https://insight.jci.org/articles/view/18742202 Mar 2026 16:05 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mg3n2umuo223https://bsky.app/profile/leibnizliv.bsky.social/post/3mexqhh26o22b🎉Excited to announce Marie-Sophie Vollmost, Katharina Budde, Cedric Mahncke & Jule Alina Russow as the new voices of our PhD community at @leibnizliv.bsky.social ! 👉 Read their personal statements & learn more here: https://www.leibniz-liv.de/en/news/news-and-press/new-phd-representatives-at-the-leibniz-institute-of-virology #PhDCommunity #LeibnizGemeinschaft16 Feb 2026 09:30 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3mexqhh26o22bhttps://bsky.app/profile/leibnizliv.bsky.social/post/3meir2g4vhs2fMit großer Betroffenheit nimmt das LIV Abschied von Prof. Dr. Oliver T. Keppler – ein langjähriger Wegbegleiter im @dzif.bsky.social und @gesvirologie.bsky.social, herausragender Forscher, geschätzter Kollege und besonderer Mensch. https://www.dzif.de/de/trauer-um-professor-oliver-t-keppler10 Feb 2026 10:31 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3meir2g4vhs2fhttps://bsky.app/profile/leibnizliv.bsky.social/post/3m7audmumbc2qCongrats to Thomas Mulvaney from the @topf-lab.bsky.social for his Nomination for the Leibniz Association’s Dissertation Award — a great recognition of his innovative work on integrative modeling of proteins and nucleic acids. #ResearchExcellence @leibnizliv.bsky.social @cssbhamburg.bsky.social05 Dec 2025 16:02 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3m7audmumbc2qhttps://bsky.app/profile/leibnizliv.bsky.social/post/3m6wuqnbnd22wHeute am @leibnizliv.bsky.social: Unser LIV-Career Day! Ein spannender Tag voller Einblicke in Karrieremöglichkeiten durch Vertreter*innen aus Journalismus, Consulting, Biotech und Forschung. Danke an alle für den inspirierenden Austausch und an das tolle Orga-Team! #PhDCareerDay #Networking01 Dec 2025 16:43 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3m6wuqnbnd22whttps://bsky.app/profile/leibnizliv.bsky.social/post/3m6p7fskgdc2lExcited to see this study from the Marcia lab (UU/EMBL), the Topf lab (LIV/UKE/CSSB), and the De Vito lab (IIT), showing sequential assembly of a self-splicing ribozyme. It beautifully shows how computational tools developed at @leibnizliv.bsky.social can resolve highly dynamic molecular assemblies. [contains quote post or other embedded content]28 Nov 2025 15:32 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3m6p7fskgdc2lhttps://bsky.app/profile/leibnizliv.bsky.social/post/3lvqbyswmps2zWie vermehren sich Viren auf molekularer Ebene – und was lässt sich daraus ableiten? Dr. Tanja Laske untersucht das mit ihrer LIV-Nachwuchsgruppe, speziell am Beispiel von Influenzaviren - mit computergestützten Analysen, Biostatistik & KI. https://www.youtube.com/watch?v=ITqLYZPjpsk @leibniz-gemeinschaft.de06 Aug 2025 13:05 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3lvqbyswmps2zhttps://bsky.app/profile/leibnizliv.bsky.social/post/3lvlgadvs3k2fHeute war Hamburgs Wissenschaftssenatorin Maryam Blumenthal zu Besuch am LIV! Dabei gab es spannende Einblicke in unsere virologische Forschung. Danke für den Besuch und den konstruktiven Austausch! https://www.leibniz-liv.de/aktuelles/news-und-presse/hamburgs-wissenschaftssenatorin-maryam-blumenthal-zu-besuch-am-liv @bwfg.bsky.social04 Aug 2025 14:37 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3lvlgadvs3k2fhttps://bsky.app/profile/leibnizliv.bsky.social/post/3lv6hizha4222Ein internationales Team – unter Beteiligung von Prof. Marcus Altfeld (LIV) – ruft in einem The Lancet HIV-Kommentar zu mehr Investitionen in die #HIV-Heilungsforschung auf. Mehr Infos: https://www.leibniz-liv.de/aktuelles/news-und-presse/aufruf-fuer-investitionen-in-der-hiv-heilungsforschung @dzif.bsky.social @leibniz-gemeinschaft.de Bild ©Adobe Stock, MingQi30 Jul 2025 10:55 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3lv6hizha4222https://bsky.app/profile/leibnizliv.bsky.social/post/3lv3xplbans2rLIV-Nachwuchsgruppenleitung Dr. Dr. Ulrike Lange erhält zwei Förderungen: 72.000 € von der Werner-Otto-Stiftung für ein Projekt zu HIV-Proviren & Immunmodulation 1,7 Mio € im Programm PROFI Transfer Plus (IFB Hamburg/EFRE) mit PROVIREX für neue Gentherapien gegen HTLV-1 #EFREhamburg lnkd.in/eYCv9FM929 Jul 2025 11:07 +0000at://did:plc:ckgyn4vtgu5iikrbycfyyfxv/app.bsky.feed.post/3lv3xplbans2r